An IFPMA delegation of research-based biopharmaceutical experts participated in the WHO Fair Pricing Forum held in Amsterdam. Coming out of the meeting, IFPMA said it welcomed the opportunity to work with all stakeholders to enhance innovation and increase patient access to medicines and vaccines. WHO Fair Pricing Forum is one-step in an evidence-based structured process...
Read moreIFPMA Director-General Thomas Cueni announced today that former PhRMA and Merck KGaA executive, Dr Fumie Griego, has joined the organization as Assistant Director General (ADG) for strategic planning, policy, and research. “I am delighted to count on the support of Fumie Griego, a highly competent professional, whom I have chosen for her strong pharma expertise...
Read moreOver the course of my lifetime, human lifespan extended by three decades. Today we hope to lead healthy lives well into our 80s. Now I have to declare a vested interest in this topic: I am an aspiring role model for active and healthy ageing (I’m past 60 and look forward to working actively for...
Read moreAs we look forward to hosting the Geneva Pharma Forum during current World Immunization Week, finding solutions to pre-empt or mitigate vaccine shortages is top-of-mind here at IFPMA and for our members. What’s more, recently the first Access to Vaccines Index (ATVI) was published – a set of report cards rich in data, and painting...
Read moreAfter 30 years in the world of policymaking and business, there is not much that can faze me; but it is fair to say that nothing could have prepared me for meeting Agnes. This has been a week when Geneva played host to ministers, scientists, WHO officials, philanthropists and business who met to take stock...
Read more